A Case Report of Steroid-Resistant Cryptogenic Organizing Pneumonia Managed with Intravenous Immunoglobulins.

Q4 Medicine
Case Reports in Pulmonology Pub Date : 2021-11-15 eCollection Date: 2021-01-01 DOI:10.1155/2021/9343491
Christian Akem Dimala, Urvi Patel, Benjamin Lloyd, Anthony Donato, William B Kimmel, Robert Hallowell, Caitlyn Moss
{"title":"A Case Report of Steroid-Resistant Cryptogenic Organizing Pneumonia Managed with Intravenous Immunoglobulins.","authors":"Christian Akem Dimala,&nbsp;Urvi Patel,&nbsp;Benjamin Lloyd,&nbsp;Anthony Donato,&nbsp;William B Kimmel,&nbsp;Robert Hallowell,&nbsp;Caitlyn Moss","doi":"10.1155/2021/9343491","DOIUrl":null,"url":null,"abstract":"<p><p>Fewer than ten reported cases of cryptogenic organizing pneumonia (COP) have been managed with intravenous immunoglobulins (IVIg). We report a case of a 72-year-old man who presented with a worsening cough and diffuse opacities on chest radiograph. Following no improvement with antibiotics and negative complementary investigations for infectious, malignant, and autoimmune etiologies, COP was confirmed on lung biopsy. Due to continued clinical deterioration despite high-dose steroids and new severe steroid-induced hallucinations, the patient was placed on intravenous immunoglobulins (IVIg) and mycophenolate mofetil and made a satisfactory recovery. IVIg should be considered as an important steroid-sparing alternative in patients with COP.</p>","PeriodicalId":52364,"journal":{"name":"Case Reports in Pulmonology","volume":"2021 ","pages":"9343491"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608529/pdf/","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Pulmonology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2021/9343491","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 4

Abstract

Fewer than ten reported cases of cryptogenic organizing pneumonia (COP) have been managed with intravenous immunoglobulins (IVIg). We report a case of a 72-year-old man who presented with a worsening cough and diffuse opacities on chest radiograph. Following no improvement with antibiotics and negative complementary investigations for infectious, malignant, and autoimmune etiologies, COP was confirmed on lung biopsy. Due to continued clinical deterioration despite high-dose steroids and new severe steroid-induced hallucinations, the patient was placed on intravenous immunoglobulins (IVIg) and mycophenolate mofetil and made a satisfactory recovery. IVIg should be considered as an important steroid-sparing alternative in patients with COP.

Abstract Image

Abstract Image

Abstract Image

静脉注射免疫球蛋白治疗类固醇抵抗性隐源性肺炎1例报告。
据报道,静脉注射免疫球蛋白(IVIg)治疗的隐源性组织性肺炎(COP)病例不到10例。我们报告一个72岁男性的病例,他在胸片上表现为咳嗽恶化和弥漫性混浊。抗生素治疗无改善,感染、恶性和自身免疫性病因的补充检查阴性,肺活检证实COP。尽管使用了大剂量类固醇,但患者的临床情况仍持续恶化,并出现了新的严重类固醇引起的幻觉,因此给予静脉注射免疫球蛋白(IVIg)和霉酚酸酯,患者恢复良好。在COP患者中,IVIg应被视为一种重要的节省类固醇的替代方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Case Reports in Pulmonology
Case Reports in Pulmonology Medicine-Pulmonary and Respiratory Medicine
CiteScore
1.80
自引率
0.00%
发文量
23
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信